-
Breaking: Catalent
$CTLT to buy Orgenesis'#celltherapy#CDMO biz Masthercell for $315m - story@BioProInsider Insider https://buff.ly/36PRRod pic.twitter.com/gdXg2Jb6nZ
-
@CatalentPharma has agreed to acquire Masthercell Global, a#CDMO subsidiary of Orgenesis based in#Belgium.#celltherapy#ATMP#biotechhttps://www.orgenesis.com/news-media/press-releases/detail/143/orgenesis-announces-agreement-for-the-sale-of-masthercell … -
Kemwell Vision is to be a global leader and first-choice CDMO for biologics. . .
#kemwell#CDMo#CMO#biologicspic.twitter.com/AxA1BamwvM
-
Our latest
#CDMO blog post is all about understanding reprogramming to generate iPSCs and how to get them#GMP ready. https://cdmo.ccrm.ca/blog/induced-pluripotent-stem-cells-in-cgt-understanding-reprogramming …pic.twitter.com/6GX00Ayd5e
-
This month's BPOR includes the launch of $1.1billion
#CDMO The Center for Breakthrough Medicines for#geneandcelltherapy#manufacturing#cmo#pharma#lifescienceshttps://twitter.com/PharmSource/status/1223246042705080322 …
-
New technological investments are a tangible sign of our ability to continue to focus on custom development and manufacturing (
#CDMO), at the same time enhancing the human capital of our operators in terms of dedication and know-how. http://bit.ly/Indena_CDMO pic.twitter.com/V5yQGLVQi2
Prikaži ovu nit -
Coripharma and Midas to cooperate on sales & marketing for pharmaceutical contract manufacturing of finished dosage forms.
#pharma#cmo#cdmo https://www.coripharma.is/news/coripharma-and-midas-to-cooperate-on-sales-marketing/ …pic.twitter.com/T6qidmgHNa
-
To optimize workflow of customer projects, we align our development service laboratory portfolio under one roof. Further expansion of laboratory space will continue throughout 2020.
#cdmo#investinfuture#customerbenefit https://bit.ly/36FhBDy pic.twitter.com/ZS6PM4ctUl
-
[ALA client news]
@yposkesi clinical batches of the G1XCGD lentiviral vector used in rare immune system disease study#GeneTherapy#CDMO https://www.ala.com/yposkesis-clinical-batches-of-the-g1xcgd-lentiviral-vector-used-in-rare-immune-system-disease-study/ …@NatureMedicinepic.twitter.com/VkDnDKrYMR
-
Kemwell accomplishments from development to manufacturing. . . .
#kemwell#CDMO#CMO#biologicspic.twitter.com/Lq9L6m08Qt
-
FDA releases six final guidances today on
#genetherapy manufacturing and clinical development of products and a draft guidance, Interpreting Sameness of Gene Therapy Products Under the Orphan Drug Regulations. https://www.fda.gov/news-events/press-announcements/fda-continues-strong-support-innovation-development-gene-therapy-products?utm_campaign=012820_Statement_FDA%20Continues%20Strong%20Support%20of%20Innovation%20in%20Gene%20Therapy&utm_medium=email&utm_source=Eloqua …#raredisease#viralvectors#CDMO -
Next month, our team will be at the 12th Annual AsiaTIDES conference in Kyoto, Japan on February 24-26. If you are planning on attending, stop by our booth to learn more about our CDMO services. We look forward to seeing you there!
#Tides365#outsourcing#CDMO pic.twitter.com/Ye7zVH85TO
-
Quay Pharma are looking forward to joining in the discussions with drug product developments leading innovators at this months 2020 Global
#Bioavailability Enhancement Summit, NY.#pharmaceuticals#CDMO#formulation https://curtiscoulter.com/2020-global-drug-bioavailability-enhancement-summit/ …pic.twitter.com/Jcd2RbTWMV
-
Quay Pharma are proud sponsors of 2020 Global
#Bioavailability Enhancement Summit, NY. Come along to discuss how Quay Pharma can help you with your project.#pharmaceuticals#CDMO#formulation https://www.quaypharma.com/ pic.twitter.com/8v5scupLU0
-
Rare diseases top another strong year for novel drug approvals . . https://www.evaluate.com/vantage/articles/data-insights/nme-approvals/rare-diseases-top-another-strong-year-novel-drug …
#kemwell#CDMO#CMO#biologicspic.twitter.com/1sMhsqzszn
-
Our PRIME project is nominated for
@medicine_maker Innovation Awards'20. Voting is now open and we would like to invite you all to vote on it at https://www.smartsurvey.co.uk/s/BRYW4/ Find more about how PRIME at https://go.hovione.com/prime-tool-overview …#processdevelopment#developmentbydesign#cdmo pic.twitter.com/lHQOxDwkTT
-
“Onyx have a tremendous reputation as a premier
#CDMO and the results they achieve consistently exceed our highest expectations.” – Peter Rands, MD at Small Pharma Ltd. See what our other customers had to say here: http://bit.ly/2RoSZuL pic.twitter.com/uopkGxYZoi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.
We analyze
Contract service agreements
M&A
Small and large molecule
Facility inspections